Equally, the Cochrane review by Vos et al. showed that addition of metformin to insulin has positive effects on glycaemic control and insulin requirements in people with type 2 diabetes and inadequate glycaemic control compared to other oral agents [12]. This evidence concerns the gene INS and type 2 diabetes mellitus.